Int J Sports Med 2000; 21(4): 270-274
DOI: 10.1055/s-2000-312
Physiology and Biochemistry
Georg Thieme Verlag Stuttgart ·New York

Exercise in the Heat: Effects of an Adenosine Antagonist

M. J. Durkot1 , L. de Garavilla2
  • 1 U.S. Army Research Institute of Environmental Medicine, Natick, MA, USA
  • 2 The R. W. Johnson Pharmaceutical Research Institute, Spring House, PA, USA
Further Information

Publication History

Publication Date:
31 December 2000 (online)

The purpose of this experiment was to examine the effects of an adenosine antagonist on cardiovascular, thermoregulatory, and exercise performance in the heat. Two doses (1 mg/kg and 10 mg/kg) of a selective adenosine A1 antagonist (1,3-di-n-propyl-8-[4-hydroxyphenyll]xanthine) (DPHPX) were tested in a rat model of exercise exhaustion, treadmill 11 m/min, 6 ° incline, in the heat 30 ° C. Pretreatment with the experimental adenosine antagonist caused a slight improvement p > 0.05 in run time (41 ± 4 vs. 44 ± 3 mm) at a low dose but reduced performance (41 ± 4 vs. 29 ± 3 mm) at a high dose despite elevated plasma lactate (6.41 ± 0.82 vs. 9.91 ± 1.0 and 12.42 ± 1.1 µmole/L) levels in both dosage groups. At the low dose the antagonist provided a clear benefit in thermoregulation as evidenced by reduced heating rates (0.079 ± 0.005 vs. 0.050 ± 0.009 °C/min). Heart rate and blood pressure tended to be preserved in the low dose group also. Blood gases remained closer to normal with either dosage of drug with arterial PO2 being remarkably preserved after exercise whereas venous PO2 was not different suggesting increased oxygen delivery and extraction. The results of this investigation indicate that antagonizing the effects of adenosine at a low dose with this agent did improve cardiovascular and thermoregulatory responses but did not provide a substantial overall benefit in exercise performance in the heat.

References

  • 1 Armstrong L E, Maresh C M, Bergeron M F, Hoffman J R, Whittlesey M J, Roy G. Exercise-heat tolerance of college distance runners at 38 NC.  J Strenth Cond Res. 1996;  10 190-196
  • 2 Bacchus A N, Ely S W, Knabb M, Rubio R, Berne R M. Adenosine and coronary blood flow in conscious dogs during normal physiological stimuli.  Am J Physiol. 1982;  243 H628-H633
  • 3 Bellardinelli L, West A, Crampton R, Berne R M. Chronotropic and dromotropic effects of adenosine. In: Berne RM, Rall TW, Rubio R (eds) Regulatory Function of Adenosine. Boston; Martinus Niehoff 1983: 377-398
  • 4 Belloni F L, Phair R D, Sparks X V. The role of adenosine in prolonged vasodilation following flow-restricted exercise of canine skeletal muscle.  Ciro Res. 1979;  44 759-766
  • 5 Clarkson P M. Nutrition for improved sports performance.  Sports Med. 1996;  21 393-401
  • 6 Costill D L, Dalsky C, Fink W. Effects of caffeine ingestion on metabolism and exercise performance.  Med Sci Sports. 1978;  10 155-158
  • 7 De Garavilla L, Tocker J E, Valentine H L, Hanson R C. A1-selective adenosine antagonists improve cardiovascular function during hemorrhagic shock in rats.  Circ. 1987;  76
  • 8 Drury A N, Szent-Cyorgi A. The physiological activity of adenine compounds with special reference to their actions upon the mammalian heart.  J Physiol London. 1929;  68 213-237
  • 9 Durkot M J, de Garavilla L, Francesconi R. The effects of dichloroacetate on lactate accumulation and endurance in an exercising rat model.  Int J Sports Med. 1995;  16 167-171
  • 10 Evans D B, Schenden A J, Bristol J A. Adenosine receptors mediating cardiac depression.  Life Sci. 1982;  30
  • 11 Fredholm B B, Sellevi A. Cardiovascular effects of adenosine.  Clin Physiol. 1986;  6 1-21
  • 12 Fuchs B D, Gorman M W, Sparks H V. Adenosine release into venous plasma during free flow exercise.   Proc Soc Exp Biol Med. 1986;  181 364-370
  • 13 Goodman A, Gilman L. The Pharmacological Basis of Therapeutics. MacMillan Publishing Company Inc. 1980 6th Edition:
  • 14 Hubbard R W, Matthew W T, Criss R EL, Kelly C, Sils I, Mager M, Bowers W D, Wolfe D. Role of Physical effort in the etiology of rat heat injury and mortality.  J Appl Physiol. 1978;  45 463-468
  • 15 Klabunde R E. Conditions for dipyridamole potentiation of skeletal muscle active hyperemia.  Am J Physiol. 1986;  250 H62-H67
  • 16 Lautt W W, Legare D J. The use of 8-phenyltheophylline as competitive antagonist of adenosine and an inhibitor of the intrinsic regulatory mechanism of the hepatic artery.  Can J Physiol Pharmacol. 1985;  63 717-722
  • 17 Meester B J, Shankly N P, Welsh N J, Wood J, Meijler F I, Black J W. Pharmacological classification of adenosine receptors in the sinoatrial and atrioventricular nodes of the guinea pig.  Br J Pharmacol. 1998;  124 685-692
  • 18 McKenzie J E, Steffen R P, Haddy F J. Relationship between adenosine and coronary resistance in conscious exercising dogs.  Am J Physiol. 1982;  242 H24-H29
  • 19 Barnhard E R. Physician Desk Reference. 6th Edition 1985
  • 20 Proctor K G, Duling B R. Adenosine and free-flow functional hyperemia in striated muscle.  Am J Physiol. 1982;  242 688-697
  • 21 Reddington M, Lee K S. Adenosine receptor subtypes: classification and distribution. Adenosine Nervous System. London, UK; Academic Press 1991: 77-102
  • 22 Rowell L B, Brengelmann G L, Blackmon J R, Twiss R D, Kusumi F. Splanchnic blood flow and metabolism in the heat-stressed man.  J Appl Physiol. 1968;  24 475-484
  • 23 Sparks H V. Skin and muscle. In: Johnson PC (ed) Peripheral Circulation. New York; Wiley 1978: 193-230
  • 24 Spriet L L, MacLean D A, Dyck D J. Caffeine ingestion and muscle metabolism during exercise in humans.  Am J Physiol. 1992;  262 891-898

Dr. M. J. Durkot

Military Nutrition and Biochemistry Division U.S. Army Research Institute of Environmental Medicine

Kansas Street Natick, MA, 01760 USA

Email: E-mail:michael.durkot@na.amedd.army.mil

    >